Posted by Michael Wonder on 07 Apr 2019
FDA’s Gottlieb heads back to AEI to tackle drug prices
4 April 2019 - The soon-to-be former commissioner wants to delve into “market failures.”
Scott Gottlieb, who will step down as commissioner of the FDA on Friday, plans to return to the American Enterprise Institute to focus on drug prices — a hotly debated area that has been peripheral to his current job, he said in an interview.
The 46-year-old physician, who has been commuting weekly to Washington from his home in Connecticut, said he plans to spend a half-dozen days a month in Washington as a resident fellow at the conservative think tank. Besides that, he said, he has no commitments for now other than taking his family to Disney World.
